Literature DB >> 19751406

Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR.

Tetsuro Ikegami1, Krishna Narayanan, Sungyong Won, Wataru Kamitani, C J Peters, Shinji Makino.   

Abstract

Rift Valley fever virus (RVFV), which belongs to the genus Phlebovirus, family Bunyaviridae, is a negative-stranded RNA virus carrying a single-stranded, tripartite RNA genome. RVFV is an important zoonotic pathogen transmitted by mosquitoes and causes large outbreaks among ruminants and humans in Africa and the Arabian Peninsula. Human patients develop an acute febrile illness, followed by a fatal hemorrhagic fever, encephalitis, or ocular diseases. A viral nonstructural protein, NSs, is a major viral virulence factor. Past studies showed that NSs suppresses the transcription of host mRNAs, including interferon-beta mRNAs. Here we demonstrated that the NSs protein induced post-transcriptional downregulation of dsRNA-dependent protein kinase (PKR), to prevent phosphorylation of eIF2alpha and promoted viral translation in infected cells. These two biological activities of the NSs most probably have a synergistic effect in suppressing host innate immune functions and facilitate efficient viral replication in infected mammalian hosts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751406      PMCID: PMC3137120          DOI: 10.1111/j.1749-6632.2009.05054.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  37 in total

1.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.

Authors:  F Urano; X Wang; A Bertolotti; Y Zhang; P Chung; H P Harding; D Ron
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

Review 2.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

3.  T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus.

Authors:  Matthias Habjan; Nicola Penski; Martin Spiegel; Friedemann Weber
Journal:  J Gen Virol       Date:  2008-09       Impact factor: 3.891

4.  Potential role of PKR in double-stranded RNA-induced macrophage activation.

Authors:  L B Maggi; M R Heitmeier; D Scheuner; R J Kaufman; R M Buller; J A Corbett
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

5.  NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis.

Authors:  Sungyong Won; Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

6.  RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.

Authors:  Agnès Billecocq; Nicolas Gauliard; Nicolas Le May; Richard M Elliott; Ramon Flick; Michèle Bouloy
Journal:  Virology       Date:  2008-07-09       Impact factor: 3.616

Review 7.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

8.  Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  Virology       Date:  2006-09-08       Impact factor: 3.616

9.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

10.  A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.

Authors:  Nicolas Le May; Zeyni Mansuroglu; Psylvia Léger; Thibaut Josse; Guillaume Blot; Agnès Billecocq; Ramon Flick; Yves Jacob; Eliette Bonnefoy; Michèle Bouloy
Journal:  PLoS Pathog       Date:  2008-01       Impact factor: 6.823

View more
  46 in total

1.  Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication.

Authors:  Alan Baer; Dana Austin; Aarthi Narayanan; Taissia Popova; Markus Kainulainen; Charles Bailey; Fatah Kashanchi; Friedemann Weber; Kylene Kehn-Hall
Journal:  J Biol Chem       Date:  2012-01-05       Impact factor: 5.157

Review 2.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

3.  A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence.

Authors:  Normand Cyr; Cynthia de la Fuente; Lauriane Lecoq; Irene Guendel; Philippe R Chabot; Kylene Kehn-Hall; James G Omichinski
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

4.  Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus.

Authors:  Bingqian Qu; Xian Qi; Xiaodong Wu; Mifang Liang; Chuan Li; Carol J Cardona; Wayne Xu; Fenyang Tang; Zhifeng Li; Bing Wu; Kira Powell; Marta Wegner; Dexin Li; Zheng Xing
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.

Authors:  Kimberly A Dodd; Brian H Bird; Maureen G Metcalfe; Stuart T Nichol; César G Albariño
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Curcumin inhibits Rift Valley fever virus replication in human cells.

Authors:  Aarthi Narayanan; Kylene Kehn-Hall; Svetlana Senina; Lindsay Lundberg; Rachel Van Duyne; Irene Guendel; Ravi Das; Alan Baer; Laura Bethel; Michael Turell; Amy Lynn Hartman; Bhaskar Das; Charles Bailey; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

7.  Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.

Authors:  Kimberly A Dodd; Anita K McElroy; Megan E B Jones; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

8.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

9.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

10.  Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.

Authors:  Kimberly K Roberts; Terence E Hill; Melissa N Davis; Michael R Holbrook; Alexander N Freiberg
Journal:  J Gen Virol       Date:  2015-03-10       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.